Patents by Inventor Lorenzo Silengo

Lorenzo Silengo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure
    Patent number: 7531714
    Abstract: The present invention concerns non-human transgenic animals as model study for human pathologies, being transgenic for having altered melusin expression. The non-human transgenic animals are to be used as models to study heart pathologies and provide therapies thereof, wherein the heart pathologies are heart failure, and in particular diluted cardiomyopathy.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: May 12, 2009
    Assignee: Universita' Degli Studi de Torino
    Inventors: Mara Brancaccio, Lorenzo Silengo, Fiorella Altruda, Giuseppe Lembo, Luigi Fratta, Guido Tarone
  • Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure
    Publication number: 20060059577
    Abstract: The present invention concerns non-human transgenic animals as model study for human pathologies, being transgenic for having altered melusin expression. The non-human transgenic animals are to be used as models to study heart pathologies and provide therapies thereof, wherein the heart pathologies are heart failure, and in particular diluted cardiomyopathy.
    Type: Application
    Filed: December 19, 2002
    Publication date: March 16, 2006
    Inventors: Mara Brancaccio, Lorenzo Silengo, Fiorella Altruda, Giuseppe Lembo, Luigi Fratta, Guido Tarone